VBIV - VBI Vaccines Inc.
Previous close
0.0653
0 0%
Share volume: 294,352
Last Updated: Wed 07 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.07
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-09 | 2022-08-08 | 2022-11-10 | 2023-03-13 | 2023-05-15 | 2023-08-14 | 2023-11-14 | |
| Total revenue | 126.000 K | 346.000 K | 317.000 K | 293.000 K | 485.000 K | 720.000 K | 6.624 M | |
| Cost of revenue | 2.754 M | 2.522 M | 2.672 M | 3.328 M | 3.559 M | 3.483 M | 2.525 M | |
| Gross profit | -2.628 M | -2.176 M | -2.355 M | -3.035 M | -3.074 M | -2.763 M | 4.099 M | |
| 17.20% | -8.23% | -28.87% | -1.29% | 10.12% | 248.35% | |||
| Operating expenses | 13.292 M | 20.727 M | 19.203 M | 18.404 M | 16.435 M | 14.209 M | 10.568 M | |
| Selling general and admin | 10.930 M | 15.084 M | 14.220 M | 15.886 M | 13.284 M | 10.917 M | 9.036 M | |
| Research and development | 2.362 M | 5.643 M | 4.983 M | 2.518 M | 3.151 M | 3.292 M | 1.532 M | |
| Total expenses | 16.046 M | 23.249 M | 21.875 M | 21.732 M | 19.994 M | 17.692 M | 13.093 M | |
| 44.89% | -5.91% | -0.65% | -8.00% | -11.51% | -25.99% | |||
| Operating income | -15.920 M | -22.903 M | -21.558 M | -21.439 M | -19.509 M | -16.972 M | -6.469 M | |
| Ebit | -15.920 M | -22.903 M | -21.558 M | -21.439 M | -19.509 M | -16.972 M | -6.469 M | |
| Pretax income | -21.254 M | -45.699 M | -25.209 M | -21.141 M | -27.751 M | -44.628 M | -20.444 M | |
| 115.01% | -44.84% | -16.14% | 31.27% | 60.82% | -54.19% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -21.254 M | -45.699 M | -25.209 M | -21.141 M | -27.751 M | -44.628 M | -21.306 M | |
| -115.01% | 44.84% | 16.14% | -31.27% | -60.82% | 52.26% | |||
| Net income | -21.254 M | -45.699 M | -25.209 M | -21.141 M | -27.751 M | -44.628 M | -21.306 M | |
| -115.01% | 44.84% | 16.14% | -31.27% | -60.82% | 52.26% |